Mode of action of ciclopiroxolamine on Candida albicans;Wirkungsweise von ciclopiroxolamin auf Candida albicans

Mycoses, Supplement

Volumn 45, Issue 1, 2002, Pages 63-68

  Niewerth, Markus ^a   Schaller, M ^a   Korting, H C ^a   Hube, B ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

Author keywords

Candida albicans; Ciclopiroxolamine; Gene expression; Iron metabolism

Indexed keywords

ANTIFUNGAL AGENT; CHELATING AGENT; CICLOPIROXOLAMINE;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; DRUG ACTIVITY; IMMUNE SYSTEM; IRON METABOLISM; PRIORITY JOURNAL; TREATMENT PLANNING; VIRULENCE;

CANDIDA ALBICANS; CANDIDIASIS; HUMANS; MICROBIAL SENSITIVITY TESTS; PYRIDONES;

CANDIDA; CANDIDA ALBICANS; FUNGI;

EID: 0036345846     PISSN: 09437312     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Zur chemie von antimikrobiell wirksamen 1-hydroxy-2-pyridonen
2. Ciclopirox olamine 1% cream. A preliminary review of its antimicrobial activity and therapeutic use
3. Ciclopiroxolamin
4. Mikrobiologische laboruntersuchungen mit ciclopiroxolamin
5. Mode of action of 6-cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone ethanolamine salt (Hoe 296)
6. Studien zum mechanismus der antimyzetischen wirkung von ciclopiroxolamin
7. Studies on uptake of 6-hydroxy-4-methyl-2(1H)-pyridone ethanolamine salt (Hoe 296) by Candida albicans
8. The effect of ciclopiroxolamine investigated by means of the freeze-fracture-technique
9. Effects of subinhibitory concentrations of ciclopirox on the adherence of Candida albicans to human buccal and vaginal epithelial cells
10. HOE 296, a new antimycotic compound with a broad antimicrobial spectrum
11. Ciclopirox olamine: A hydroxypyridone antifungal agent
12. The hydroxypyridones: A class of antimycotics of its own
13. Studies for the elucidation of the mode of action of the antimycotic hydroxypyridone compound, rilopirox
14. Ultrastructural investigations of Candida albicans after in vitro treatment with the new fungicidal agent rilopirox
15. Inhibition of Candida albicans adhesiveness to human buccal and vaginal cells by sub-inhibitory concentrations of rilopirox
16. Experimental evidences for a role of subinhibitory concentrations of rilopirox, nystatin and fluconazole on adherence of Candida spp. to vaginal epithelial cells
17. A high-affinity iron permease essential for Candida albicans virulence
18. Candida albicans CFL1 encodes a functional ferric reductase activity that can rescue a Saccharomyces cerevisiae fre1 mutant
19. A multicopper oxidase gene from Candida albicans: Cloning, characterisation and disruption
20. Role of the Candida albicans copper transporter CaCCC2 in high-affinity iron import
21. The Menkes/Wilson disease gene homologue in yeast provides copper to a ceruloplasmin-like oxidase required for iron uptake
22. Cloning and sequencing of a Candida albicans catalase gene and effects of disruption of this gene
23. Analysis of a Candida albicans gene that encodes a novel mechanism for resistance to benomyl and methotrexate
24. A novel multidrug efflux transporter gene of the major facilitator family from Candida albicans (FLU1) conferring resistance to fluconazole
25. Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals
26. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: Characterization of CDR2, a new multidrug ABC transporter gene
27. The Candida albicans CDR3 gene codes far an opaque-phase ABC transporter
28. A fourth gene from the Candida albicans CDR family of ABC transporter